Belvarafenib, a novel pan-RAF inhibitor, in solid tumor patients harboring BRAF, KRAS, or NRAS mutations: Phase I study
Kim, Tae Won, Lee, Jeeyun, Shin, Sang Joon, Kim, Jin-Soo, Kim, Yu Jung, Han, Hye Sook, Lee, Soo Jung, Lim, Hyeong-Seok, Hong, Yoon-hee, Noh, Young Su, Kyoung, Yujung, Han, Oakpil, Yoon, Jiyeon, Lim, Jeong Ah, Kim, Suk Ran
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article